The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression
- 1 August 2008
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 9 (9) , 1019-1027
- https://doi.org/10.1038/ni.1640
Abstract
The function of the kinase p38α in inflammation is unclear. Park and colleagues show that p38α exerts pro- or anti-inflammatory effects depending on the cell type in which it is expressed and the stimulus eliciting its activation. The mitogen-activated protein kinase p38 mediates cellular responses to injurious stress and immune signaling. Among the many p38 isoforms, p38α is the most widely expressed in adult tissues and can be targeted by various pharmacological inhibitors. Here we investigated how p38α activation is linked to cell type–specific outputs in mouse models of cutaneous inflammation. We found that both myeloid and epithelial p38α elicit inflammatory responses, yet p38α signaling in each cell type served distinct inflammatory functions and varied depending on the mode of skin irritation. In addition, myeloid p38α limited acute inflammation via activation of anti-inflammatory gene expression dependent on mitogen- and stress-activated kinases. Our results suggest a dual function for p38α in the regulation of inflammation and show mixed potential for its inhibition as a therapeutic strategy.Keywords
This publication has 53 references indexed in Scilit:
- NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβCell, 2007
- p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathwayNature Genetics, 2007
- Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferationThe EMBO Journal, 2007
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expressionJournal of Leukocyte Biology, 2004
- Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responsesNature Medicine, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genesGenes & Development, 2002
- Deficiency of the Stress Kinase P38α Results in Embryonic LethalityThe Journal of Experimental Medicine, 2000
- Novel Homologues of CSBP/p38 MAP Kinase: Activation, Substrate Specificity and Sensitivity to Inhibition by Pyridinyl ImidazolesBiochemical and Biophysical Research Communications, 1997